ES8307495A1 - Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica. - Google Patents

Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica.

Info

Publication number
ES8307495A1
ES8307495A1 ES508185A ES508185A ES8307495A1 ES 8307495 A1 ES8307495 A1 ES 8307495A1 ES 508185 A ES508185 A ES 508185A ES 508185 A ES508185 A ES 508185A ES 8307495 A1 ES8307495 A1 ES 8307495A1
Authority
ES
Spain
Prior art keywords
organophosphonates
compositions containing
gold salts
containing gold
arthritic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508185A
Other languages
English (en)
Other versions
ES508185A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of ES508185A0 publication Critical patent/ES508185A0/es
Publication of ES8307495A1 publication Critical patent/ES8307495A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICION FARMACEUTICA INDICADA PARA ESTADOS ARTRITICOS Y ESPECIALMENTE EN LA ARTRITIS REUMATOIDE. COMPRENDE UN COMPUESTO DE ORGANOFOSFONATO, PARTICULARMENTE UN DIFOSFONATO GEMINAL TAL COMO ACIDO DICLOROMETANO DIFOSFONICO, JUNTO CON UNA SAL DE ORO FARMACEUTICAMENTE ACEPTABLE TAL COMO EL TIOMALATO DE ORO Y SODIO.
ES508185A 1980-12-22 1981-12-21 Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica. Expired ES8307495A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/219,052 US4330530A (en) 1980-12-22 1980-12-22 Anti-arthritic compositions and method using gold salts and organophosphonates

Publications (2)

Publication Number Publication Date
ES508185A0 ES508185A0 (es) 1983-08-01
ES8307495A1 true ES8307495A1 (es) 1983-08-01

Family

ID=22817643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508185A Expired ES8307495A1 (es) 1980-12-22 1981-12-21 Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica.

Country Status (6)

Country Link
US (1) US4330530A (es)
EP (1) EP0054997B1 (es)
JP (1) JPS57171922A (es)
CA (1) CA1164345A (es)
DE (1) DE3174098D1 (es)
ES (1) ES8307495A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
US4877603A (en) * 1987-12-18 1989-10-31 The Procter & Gamble Company Oral compositions
JPH01165526A (ja) * 1987-12-21 1989-06-29 Smith Kline Fujisawa Kk オーラノフィン坐剤
NZ228367A (en) * 1988-03-23 1992-02-25 Smithkline Beecham Corp Topical composition containing a gold compound for treating inflammatory conditions
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
CA2138366C (en) * 1992-06-30 1998-09-22 Kristine Hovancik Methods for the treatment of arthritis using phosphonates and nsaids
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
US7229841B2 (en) 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
WO2002040073A1 (en) * 2000-11-20 2002-05-23 Université De Genève Endosseous implant
EP1694301A4 (en) * 2003-12-02 2009-11-18 Cytimmune Sciences Inc METHOD AND COMPOSITIONS FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES
EP1715971A4 (en) * 2004-01-28 2010-10-13 Cytimmune Sciences Inc FUNCTIONALIZED COLLOIDAL METAL COMPOSITIONS AND METHODS
US8771750B2 (en) * 2006-12-14 2014-07-08 Savannah River Nuclear Solutions, Llc Delivery or removal of metals from biological systems
JP2011520769A (ja) * 2007-09-21 2011-07-21 サイトイミューン サイエンシズ インコーポレイテッド ナノ治療コロイド金属組成物および方法
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
US7960145B2 (en) * 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
WO2019081428A1 (en) * 2017-10-23 2019-05-02 INSERM (Institut National de la Santé et de la Recherche Médicale) COMPOUNDS FOR THE TREATMENT OF CMV RELATED DISEASES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE463805C (de) * 1925-06-23 1928-08-03 Leopold Cassella & Co G M B H Verfahren zur Darstellung haltbarer, sterilisierbarer Loesungen, die Phosphor in organischer Bindung sowie gebundenes Gold enthalten
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3584125A (en) * 1968-12-23 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553315A (en) * 1968-12-24 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3678164A (en) * 1969-02-12 1972-07-18 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3641246A (en) * 1970-01-14 1972-02-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phcosphate in animal tissue
US3662066A (en) * 1970-03-04 1972-05-09 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4096247A (en) * 1977-02-16 1978-06-20 Smithkline Corporation Gold thio glucopyranoside compounds and method of use
US4216212A (en) * 1978-06-08 1980-08-05 The Procter & Gamble Company Pyrazolidine anti-inflammatory composition and methods of use

Also Published As

Publication number Publication date
JPS57171922A (en) 1982-10-22
CA1164345A (en) 1984-03-27
ES508185A0 (es) 1983-08-01
EP0054997A1 (en) 1982-06-30
DE3174098D1 (en) 1986-04-17
EP0054997B1 (en) 1986-03-12
US4330530A (en) 1982-05-18

Similar Documents

Publication Publication Date Title
ES8307495A1 (es) Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica.
AU6760987A (en) Method of treating alzheimer's disease
ES8801546A1 (es) Un procedimiento para la preparacion de compuesto de 2,2-difluoronucleosidos.
GR74609B (es)
DE3579419D1 (de) Einstufiges hydrobehandlungsverfahren.
ZA853571B (en) Compositions and process for treating textiles
YU45719B (sh) Postopek za pripravo mešano substituiranih enantiomerno čistih 1,2-diacil-sn-gli cero-3-fosfoholinov in 1,2-di-acil-sn-glicero-3-fosfoetanolaminov
GB8318990D0 (en) Treatment of wounds
EP0058697A4 (en) NOVEL TYPE OF NONA- AND DECA (H -) - RUTINE SULFATES, PROCESSES FOR PREPARING SUCH NEW TYPES OF SALTS, AND USE THEREOF AS COMPLEMENTARY INHIBITORS.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
NZ216050A (en) Bromocriptine compositions for treating psychostimulant addiction
GB2136791B (en) Sewage treatment plant
JPS5225450A (en) Method of treating sludge
DE3368177D1 (en) Water treatment methods and compositions
AU560067B2 (en) Treating waste water with high ammonia/hydrogen sulphide ratio
JPS56168750A (en) Method of treating blood purifier
JPS51128474A (en) Process for treating of microbial cells
SU1212056A1 (ru) Способ термической обработки металлических изделий
JPS5542583A (en) Red tide treating method
DE3583337D1 (de) Zusammensetzung zur behandlung von haemorroiden.
JPS522055A (en) Method of treating sludge
ES8707478A1 (es) Procedimiento para la esterilizacion de agua con cloro
SU1154903A1 (ru) Способ получения 2-имино-3-фенил-6-фенацилиден-2,3,5,6 -тетрагидро-1,3,4-оксадиазин-5-онов
SU1031367A1 (ru) Способ обработки структур кремний-двуокись кремния
GB2152831B (en) Water treatment plant

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506